148 related articles for article (PubMed ID: 36580307)
41. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
42. Short- and long-term outcome following laparoscopic versus open resection for carcinoma of the rectum in the multimodal setting.
Kellokumpu IH; Kairaluoma MI; Nuorva KP; Kautiainen HJ; Jantunen IT
Dis Colon Rectum; 2012 Aug; 55(8):854-63. PubMed ID: 22810470
[TBL] [Abstract][Full Text] [Related]
43. Long-term oncologic outcomes of robotic low anterior resection for rectal cancer: a comparative study with laparoscopic surgery.
Park EJ; Cho MS; Baek SJ; Hur H; Min BS; Baik SH; Lee KY; Kim NK
Ann Surg; 2015 Jan; 261(1):129-37. PubMed ID: 24662411
[TBL] [Abstract][Full Text] [Related]
44. Minimally invasive surgery in elderly patients with rectal cancer: An analysis of the Bi-National Colorectal Cancer Audit (BCCA).
van Harten MJ; Greenwood EB; Bedrikovetski S; Dudi-Venkata NN; Hunter RA; Kroon HM; Sammour T
Eur J Surg Oncol; 2020 Sep; 46(9):1649-1655. PubMed ID: 32312590
[TBL] [Abstract][Full Text] [Related]
45. Neoadjuvant-intensified treatment for rectal cancer: time to change?
Musio D; De Felice F; Bulzonetti N; Guarnaccia R; Caiazzo R; Bangrazi C; Raffetto N; Tombolini V
World J Gastroenterol; 2013 May; 19(20):3052-61. PubMed ID: 23716984
[TBL] [Abstract][Full Text] [Related]
46. Optimal Timing to Surgery after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
Sun Z; Adam MA; Kim J; Shenoi M; Migaly J; Mantyh CR
J Am Coll Surg; 2016 Apr; 222(4):367-74. PubMed ID: 26897480
[TBL] [Abstract][Full Text] [Related]
47. Definitive Chemoradiation for Rectal Cancer: Is There a Role for Dose Escalation? A National Cancer Database Study.
Wegner RE; Hasan S; Renz PB; Raj MS; Monga DK; Finley GG; Kirichenko AV; McCormick JT
Dis Colon Rectum; 2019 Nov; 62(11):1336-1343. PubMed ID: 31567930
[TBL] [Abstract][Full Text] [Related]
48. Preoperative long course chemoirradiation in a developing country for rectal carcinoma: Kuala Lumpur hospital experience.
Lee WC; Yusof MM; Lau FN; Phua VC
Asian Pac J Cancer Prev; 2013; 14(6):3941-4. PubMed ID: 23886211
[TBL] [Abstract][Full Text] [Related]
49. Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy.
Delitto D; George TJ; Loftus TJ; Qiu P; Chang GJ; Allegra CJ; Hall WA; Hughes SJ; Tan SA; Shaw CM; Iqbal A
J Natl Cancer Inst; 2018 May; 110(5):460-466. PubMed ID: 29165692
[TBL] [Abstract][Full Text] [Related]
50. Short-course Versus Long-course Neoadjuvant Therapy for Non-metastatic Rectal Cancer: Patterns of Care and Outcomes From the National Cancer Database.
Dutta SW; Alonso CE; Jones TC; Waddle MR; Janowski EM; Trifiletti DM
Clin Colorectal Cancer; 2018 Dec; 17(4):297-306. PubMed ID: 30146228
[TBL] [Abstract][Full Text] [Related]
51. Short-term preoperative radiotherapy is a safe approach for treatment of locally advanced rectal cancer.
Korkolis DP; Plataniotis GD; Gondikakis E; Xinopoulos D; Koulaxouzidis GV; Katsilieris J; Vassilopoulos PP
Int J Colorectal Dis; 2006 Jan; 21(1):1-6. PubMed ID: 15947936
[TBL] [Abstract][Full Text] [Related]
52. Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma.
Jia AY; Narang A; Safar B; Zaheer A; Murphy A; Azad NS; Gearhart S; Fang S; Efron J; Warczynski T; Hacker-Prietz A; Meyer J
Radiat Oncol; 2019 Aug; 14(1):147. PubMed ID: 31426827
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.
Wang L; Li ZY; Li ZW; Li YH; Sun YS; Ji JF; Gu J; Cai Y
Dis Colon Rectum; 2015 Feb; 58(2):186-92. PubMed ID: 25585076
[TBL] [Abstract][Full Text] [Related]
54. Anal adenocarcinoma: Treatment outcomes and trends in a rare disease entity.
Wegner RE; White RJ; Hasan S; Raj M; Monga D; Finley G; Kirichenko AV; McCormick J
Cancer Med; 2019 Jul; 8(8):3855-3863. PubMed ID: 31173487
[TBL] [Abstract][Full Text] [Related]
55. Oncologic and Clinicopathologic Outcomes of Robot-Assisted Total Mesorectal Excision for Rectal Cancer.
Pai A; Marecik SJ; Park JJ; Melich G; Sulo S; Prasad LM
Dis Colon Rectum; 2015 Jul; 58(7):659-67. PubMed ID: 26200680
[TBL] [Abstract][Full Text] [Related]
56. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
Cercek A; Roxburgh CSD; Strombom P; Smith JJ; Temple LKF; Nash GM; Guillem JG; Paty PB; Yaeger R; Stadler ZK; Seier K; Gonen M; Segal NH; Reidy DL; Varghese A; Shia J; Vakiani E; Wu AJ; Crane CH; Gollub MJ; Garcia-Aguilar J; Saltz LB; Weiser MR
JAMA Oncol; 2018 Jun; 4(6):e180071. PubMed ID: 29566109
[TBL] [Abstract][Full Text] [Related]
57. Propensity-score matched analysis of the pathologic outcomes and survival benefits of neoadjuvant therapy in stage II-III anal adenocarcinoma.
Emile SH; Horesh N; Garoufalia Z; Gefen R; Zhou P; Wexner SD
J Surg Oncol; 2023 Sep; 128(4):585-594. PubMed ID: 37183543
[TBL] [Abstract][Full Text] [Related]
58. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
59. Neoadjuvant Radiotherapy Versus Surgery Alone for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors: A Prospective Multicenter Stratified Randomized Trial.
Deng X; Liu P; Jiang D; Wei M; Wang X; Yang X; Zhang Y; Wu B; Liu Y; Qiu M; Zhuang H; Zhou Z; Li Y; Xu F; Wang Z
Ann Surg; 2020 Dec; 272(6):1060-1069. PubMed ID: 31599809
[TBL] [Abstract][Full Text] [Related]
60. Feasibility of modified short-course radiotherapy combined with a chemoradiosensitizer for T3 rectal cancer.
Beppu N; Matsubara N; Kakuno A; Doi H; Kamikonya N; Yamanaka N; Yanagi H; Tomita N
Dis Colon Rectum; 2015 May; 58(5):479-87. PubMed ID: 25850834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
